Northern Lights Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$650K Buy
542
+199
+58% +$203K 0.35% 38
2026
Q1
$316K Buy
343
+48
+16% +$48.7K 0.21% 47
2025
Q4
$317K Buy
+295
New +$282K 0.22% 47

Other funds holding LLY

Northern Lights Advisors's LLY Position: Q2 2026 in Review

Northern Lights Advisors increased its Eli Lilly (LLY) stake by 58% in Q2 2026, buying an estimated $203K and bringing the position to 542 shares worth $650K. The position accounts for 0.35% of the portfolio, ranked #38.

Northern Lights Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Northern Lights Advisors held 542 shares of Eli Lilly worth $650K as of Q2 2026.
  • Northern Lights Advisors bought 199 Eli Lilly shares in Q2 2026, an estimated $203K.
  • Eli Lilly made up 0.35% of Northern Lights Advisors's portfolio in Q2 2026, its #38 holding.
  • Northern Lights Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Northern Lights Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.